Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1940272 AUSTIN, TX
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,814,001
-$6,119,133 QoQ
Shares Held
600,999
-55.9% QoQ
Ownership
0.604%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#21
of 208 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. SPRY ranks #77 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in SPRY

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,814,001 600,999
2026-03-31 $10,933,134 1,361,536
2025-12-31 $4,305,478 369,569
2025-09-30 $595,261 59,230